| NCT06732804 | Alvotech Swiss AG | Healthy Male and Female Subjects | 2025-02-11 | PHASE1 |
| NCT03577782 | Hospitales Universitarios Virgen del Rocío|Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | HIV Infections | 2018-09 | PHASE1|PHASE2 |
| NCT02039505 | Takeda | Ulcerative Colitis | 2014-02-04 | PHASE3 |
| NCT06443502 | Takeda | Pouchitis | 2024-11-19 | PHASE3 |
| NCT02723006 | Millennium Pharmaceuticals, Inc. | Melanoma | 2016-06-22 | PHASE1 |
| NCT01224171 | Millennium Pharmaceuticals, Inc. | Crohn´s Disease | 2010-11 | PHASE3 |
| NCT03802214 | Stanford University|Takeda|University of Western Ontario, Canada|University of California, San Diego | Ulcerative Colitis | 2020-10-29 | |
| NCT02953275 | University of Miami|Takeda | Crohn Disease | 2017-04-13 | EARLY_PHASE1 |
| NCT02862132 | Shaare Zedek Medical Center | Crohn´s Disease|Ulcerative Colitis|Inflammatory Bowel Disease | 2017-01 | NA |
| NCT02972450 | ANRS, Emerging Infectious Diseases|European Commission|Swiss Government|Medical Research Council|FIT Biotech Ltd.|Fred Hutchinson Cancer Center|University College, London|Centre Hospitalier Universitaire Vaudois|Imperial College London|Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" IRCCS|Universit?tsklinikum Hamburg-Eppendorf|Institut d´Investigacions Biomèdiques August Pi i Sunyer|Henri Mondor University Hospital|European Georges Pompidou Hospital|Saint-Louis Hospital, Paris, France | HIV-1-infection | 2019-02-20 | PHASE1|PHASE2 |
| NCT06856135 | Takeda | Crohn´s Disease|Ulcerative Colitis | | |
| NCT07123350 | Vanderbilt University Medical Center|Takeda Pharmaceuticals U.S.A., Inc. | Inflammatory Bowel Disease (IBD)|Crohn&Amp;#39;s Disease (CD)|Ulcerative Colitis (UC) | 2025-10-16 | |
| NCT02728895 | Takeda | Allogeneic Hematopoietic Stem Cell Transplantation | 2016-06-15 | PHASE1 |
| NCT06100289 | Takeda | Ulcerative Colitis|Crohn´s Disease | 2025-01-22 | PHASE3 |
| NCT06405087 | Takeda | Ulcerative Colitis|Crohn´s Disease | 2025-10-27 | PHASE3 |
| NCT06257706 | Alimentiv Inc.|Takeda | Moderately to Severely Active Crohn´s Disease|Crohn Disease|Disease Crohn | 2024-08-07 | PHASE4 |
| NCT06609447 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Ulcerative Colitis | 2024-09-21 | PHASE4 |
| NCT02913508 | Takeda | Ulcerative Colitis|Crohn´s Disease | 2014-04 | PHASE2 |
| NCT04779320 | Takeda | Crohn´s Disease (CD) | 2022-02-10 | PHASE3 |
| NCT07398586 | Second Affiliated Hospital of Wenzhou Medical University | Ulcerative Colitis (UC) | 2020-01-01 | PHASE4 |
| NCT02611830 | Takeda | Colitis, Ulcerative | 2015-12-18 | PHASE3 |
| NCT01981616 | Millennium Pharmaceuticals, Inc. | Inflammatory Bowel Disease | 2011-09 | PHASE1 |
| NCT06095596 | Sixth Affiliated Hospital, Sun Yat-sen University | Ulcerative Colitis (UC) | 2023-11-01 | NA |
| NCT03147859 | Ottawa Hospital Research Institute|Cheo Research Institute|Nebraska Centre for Substance Abuse Research | HIV-infection+AIDS | 2017-11-01 | PHASE2 |
| NCT06873711 | Second Affiliated Hospital of Wenzhou Medical University | Colitis, Ulcerative | 2020-01-01 | |
| NCT06581328 | Takeda | Ulcerative Colitis|Crohn´s Disease | 2025-03-27 | PHASE4 |
| NCT02878083 | Nantes University Hospital|Takeda|Mauna Kea Technologies|Institut National de la Santé Et de la Recherche Médicale, France | ULCERATIVE COLITIS | 2017-01-11 | NA |
| NCT03375424 | Ced Service GmbH | Inflammatory Bowel Diseases|Treatment | 2017-10-02 | |
| NCT02497469 | Takeda | Colitis, Ulcerative | 2015-06-29 | PHASE3 |
| NCT02712866 | Parc de Salut Mar | Inflammatory Bowel Disease | 2017-01 | |
| NCT06227910 | Takeda | Crohn´s Disease | 2025-01-02 | PHASE3 |
| NCT04002180 | Takeda | Crohn´s Disease | 2019-07-01 | |
| NCT03234907 | Takeda | Crohn´s Disease | 2017-08-03 | PHASE3 |
| NCT02929316 | AGA Clinical Research Associates, LLC|Takeda | Celiac Disease | 2018-06-25 | PHASE2 |
| NCT04919252 | Yonsei University | Crohn´s Disease and Ulcerative Colitis | 2021-06-01 | PHASE3 |
| NCT05132166 | University Health Network, Toronto | Graft Vs Host Disease | 2021-12-22 | PHASE2 |
| NCT00783692 | Millennium Pharmaceuticals, Inc. | Crohn´s Disease | 2008-12 | PHASE3 |
| NCT02820493 | Universita degli Studi di Genova | Crohn Disease | 2016-09 | PHASE4 |
| NCT03329209 | Takeda | Colitis, Ulcerative|Crohn Disease | 2018-03-05 | PHASE1 |
| NCT05928039 | University of Calgary|Alimentiv Inc. | Crohn Disease | 2023-10-25 | PHASE4 |
| NCT06180382 | Centre Hospitalier Universitaire de Saint Etienne|Takeda France | Crohn´s Disease | 2024-10-31 | PHASE4 |
| NCT07273760 | AryoGen Pharmed Co. | Ulcerative Colitis (UC)|Crohn Disease (CD)|Inflammatory Bowel Disease (IBD) | 2023-07-16 | |
| NCT03657160 | Millennium Pharmaceuticals, Inc. | Hematopoietic Stem Cells | 2019-02-06 | PHASE3 |
| NCT06249555 | Alimentiv Inc.|Takeda | Crohn´s Disease | 2024-03-20 | |
| NCT02324699 | Icahn School of Medicine at Mount Sinai|Takeda | Crohn´s Disease | 2016-04 | PHASE4 |
| NCT02743806 | Takeda | Colitis, Ulcerative|Crohn Disease | 2016-08-01 | PHASE4 |
| NCT03948581 | Takeda | Healthy Volunteers | 2018-02-21 | PHASE1 |
| NCT05515029 | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Acute Lymphoblastic Leukemia|Myeloblastic Leukemia|Biphenotypic Acute Leukemia|Malignant Lymphoma|Myelodysplastic Syndromes|Juvenile Myelomonocytic Leukemia | 2022-08-23 | PHASE3 |
| NCT05158517 | Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives|Takeda | Inflammatory Bowel Diseases | 2022-03-20 | |
| NCT04797325 | University of Copenhagen | Immune-Mediated Colitis | 2021-08-30 | PHASE2 |
| NCT02559713 | Takeda | Colitis, Ulcerative|Crohn´s Disease | 2017-11-29 | PHASE4 |
| NCT05530122 | Tampere University Hospital | Ulcerative Colitis | 2009-01 | |
| NCT06626165 | Showa Inan General Hospital | Ulcerative Colitis | 2024-07-20 | PHASE4 |
| NCT03138655 | Takeda|Takeda Development Center Americas, Inc. | Ulcerative Colitis|Crohn´s Disease | 2017-11-08 | PHASE2 |
| NCT00619489 | Millennium Pharmaceuticals, Inc. | Ulcerative Colitis|Crohn´s Disease | 2007-12 | PHASE2 |
| NCT06570772 | Alvotech Swiss AG | Ulcerative Colitis | 2024-09-23 | PHASE3 |
| NCT02630966 | Takeda | Crohn´s Disease | 2016-08-10 | PHASE4 |
| NCT07576452 | University Hospital, Clermont-Ferrand|Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives | Ulcerative Colitis (UC) | 2026-06-01 | PHASE4 |
| NCT02678052 | Takeda|The Organization of Teratology Information Specialists | Colitis, Ulcerative|Crohn´s Disease | 2015-12-01 | |
| NCT05386290 | Peking Union Medical College Hospital | Ulcerative Colitis|Crohn Disease | 2020-07-09 | |
| NCT03035058 | Takeda | Primary Sclerosing Cholangitis|Inflammatory Bowel Disease | 2017-02 | PHASE3 |
| NCT03949621 | Takeda | Healthy Volunteers | 2018-02-06 | PHASE1 |
| NCT07442045 | Sixth Affiliated Hospital, Sun Yat-sen University | Ulcerative Colitis (UC) | 2023-01-01 | |
| NCT06646016 | Therakos LLC | Immune-related Colitis | 2025-12-15 | PHASE2 |
| NCT02163421 | Takeda | Healthy | 2014-06 | PHASE1 |
| NCT05837897 | Takeda | Crohn´s Disease | 2023-06-16 | PHASE3 |
| NCT02768532 | Centre Hospitalier Universitaire de Saint Etienne|Theradiag|Takeda | Crohn Disease | 2016-07-01 | PHASE4 |
| NCT05702879 | Insel Gruppe AG, University Hospital Bern|Bristol-Myers Squibb | Ulcerative Colitis | 2023-09-06 | |
| NCT05442567 | Takeda | Ulcerative Colitis|Crohn´s Disease | 2023-05-16 | PHASE3 |
| NCT02694588 | University Hospital Schleswig-Holstein | IBD | 2014-06 | NA |
| NCT02646683 | Geert D´Haens|Takeda | Crohn Disease | 2015-07 | PHASE4 |
| NCT05186623 | Asan Medical Center | Ulcerative Colitis | 2022-02-05 | |
| NCT04738942 | Takeda | Ulcerative Colitis|Crohn´s Disease | 2021-06-04 | PHASE3 |
| NCT03029143 | Takeda | Colitis, Ulcerative | 2017-03-29 | PHASE4 |
| NCT03043677 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Disease | 2016-04-01 | |
| NCT02834754 | Marc Schwartz|Takeda | Crohn´s Disease | 2018-12-01 | PHASE2 |
| NCT06880744 | AbbVie | Ulcerative Colitis | 2025-06-17 | PHASE3 |
| NCT02425111 | Takeda | Crohn´s Disease | 2015-03-30 | PHASE3 |
| NCT03824561 | Takeda | Ulcerative Colitis | 2019-02-01 | |
| NCT04804540 | Takeda | Ulcerative Colitis|Crohn Disease | 2021-12-08 | PHASE4 |
| NCT03142321 | Washington University School of Medicine | Crohn Disease of Small Intestine | 2018-06-08 | PHASE4 |
| NCT06841705 | Shilpa Grover, MD, MPH|Dana-Farber+Brigham and Women´s Cancer Center|Takeda | Immune Checkpoint Inhibitor-Related Colitis | 2025-07-15 | PHASE2 |
| NCT04407247 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Colitis|Lung Non-Small Cell Carcinoma|Malignant Genitourinary System Neoplasm|Malignant Solid Neoplasm|Melanoma | 2020-07-09 | PHASE1|PHASE2 |
| NCT03885713 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2019-09-10 | PHASE4 |
| NCT06691061 | Humanitas Clinical and Research Center | Ulcerative Colitis (Disorder) | 2023-08-01 | |
| NCT02038920 | Takeda | Crohn´s Disease | 2014-01-28 | PHASE3 |
| NCT04006080 | Guy´s and St Thomas´ NHS Foundation Trust|Takeda | Ulcerative Colitis | 2019-07-01 | PHASE4 |
| NCT05205603 | Sixth Affiliated Hospital, Sun Yat-sen University | Ulcerative Colitis|Efficacy, Self|Biologics|Mesalazine | 2022-01-15 | PHASE4 |
| NCT02674308 | Takeda | Ulcerative Colitis and Crohn´s Disease | 2015-03-24 | |
| NCT03221036 | Takeda | Moderately to Severely Active Ulcerative Colitis | 2017-08-03 | PHASE3 |
| NCT02760615 | Takeda | Colitis, Ulcerative|Crohn Disease | 2016-11-01 | PHASE4 |
| NCT00783718 | Millennium Pharmaceuticals, Inc. | Ulcerative Colitis | 2009-01 | PHASE3 |
| NCT06850727 | Odyssey Therapeutics | Ulcerative Colitis (UC)|UC - Ulcerative Colitis | 2025-06-02 | PHASE2 |
| NCT02646657 | Geert D´Haens|Takeda | Colitis, Ulcerative | 2015-07 | PHASE4 |
| NCT05281614 | Benaroya Research Institute|University of California, San Diego | Type 1 Diabetes | 2022-09-21 | EARLY_PHASE1 |
| NCT01177228 | Millennium Pharmaceuticals, Inc. | Ulcerative Colitis | 2007-05 | PHASE2 |
| NCT00790933 | Takeda | Ulcerative Colitis|Crohn´s Disease | 2009-05-22 | PHASE3 |
| NCT06066840 | The First Affiliated Hospital of Soochow University|The First Affiliated Hospital with Nanjing Medical University|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|Affiliated Hospital of Nantong University | Safety and Efficacy | 2022-08-01 | PHASE4 |
| NCT02764762 | Takeda | Crohn Disease | 2017-04-18 | PHASE4 |
| NCT05481619 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Ulcerative Colitis | 2021-01-01 | PHASE4 |
| NCT06095128 | Takeda | Ulcerative Colitis | 2024-06-12 | PHASE4 |
| NCT02790138 | Takeda | Pouchitis | 2016-10-12 | PHASE4 |
| NCT03196427 | Takeda|Takeda Development Center Americas, Inc. | Ulcerative Colitis|Crohn´s Disease | 2018-07-30 | PHASE2 |
| NCT02620046 | Takeda | Colitis, Ulcerative|Crohn´s Disease | 2016-04-15 | PHASE3 |
| NCT03819296 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Clinical Stage 0 Cutaneous Melanoma AJCC v8|Clinical Stage I Cutaneous Melanoma AJCC v8|Clinical Stage IA Cutaneous Melanoma AJCC v8|Clinical Stage IB Cutaneous Melanoma AJCC v8|Clinical Stage II Cutaneous Melanoma AJCC v8|Clinical Stage IIA Cutaneous Melanoma AJCC v8|Clinical Stage IIB Cutaneous Melanoma AJCC v8|Clinical Stage IIC Cutaneous Melanoma AJCC v8|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Colitis|Lung Non-Small Cell Carcinoma|Malignant Genitourinary System Neoplasm|Malignant Solid Neoplasm|Pathologic Stage 0 Cutaneous Melanoma AJCC v8|Pathologic Stage I Cutaneous Melanoma AJCC v8|Pathologic Stage IA Cutaneous Melanoma AJCC v8|Pathologic Stage IB Cutaneous Melanoma AJCC v8|Pathologic Stage II Cutaneous Melanoma AJCC v8|Pathologic Stage IIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIC Cutaneous Melanoma AJCC v8|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Stage 0 Lung Cancer AJCC v8|Stage I Lung Cancer AJCC v8|Stage IA1 Lung Cancer AJCC v8|Stage IA2 Lung Cancer AJCC v8|Stage IA3 Lung Cancer AJCC v8|Stage IB Lung Cancer AJCC v8|Stage II Lung Cancer AJCC v8|Stage IIA Lung Cancer AJCC v8|Stage IIB Lung Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8 | 2021-02-21 | PHASE1 |
| NCT06815003 | City of Hope Medical Center|National Cancer Institute (NCI) | Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Chronic Myelomonocytic Leukemia|Graft Versus Host Disease|Myelodysplastic Syndrome|Myeloproliferative Neoplasm | 2025-04-18 | PHASE2 |
| NCT02611817 | Takeda | Crohn´s Disease | 2016-01-04 | PHASE3 |
| NCT06584162 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Inflammatory Bowel Diseases | 2023-02-09 | PHASE4 |
| NCT03961295 | Takeda | Healthy Volunteers | 2018-02-22 | PHASE1 |
| NCT06961435 | Second Affiliated Hospital of Wenzhou Medical University | Colitis, Ulcerative | 2019-01-01 | |
| NCT03961308 | Takeda | Healthy Volunteers | 2018-03-12 | PHASE1 |
| NCT06788340 | Odense University Hospital | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis | 2025-09-01 | PHASE4 |
| NCT07495644 | Assiut University | Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis) | 2026-03-01 | |
| NCT04779307 | Takeda | Colitis, Ulcerative | 2021-10-19 | PHASE3 |
| NCT06337695 | University of Calgary | Cancer|Cancer Metastatic | 2024-07-01 | PHASE2|PHASE3 |
| NCT02954159 | Medical College of Wisconsin|Takeda | Ulcerative Colitis | 2017-05-18 | PHASE3 |
| NCT02993783 | Millennium Pharmaceuticals, Inc. | Allogeneic Hematopoietic Stem Cell Transplantation | 2017-04-28 | PHASE2 |
| NCT06317220 | Massachusetts General Hospital|Dana-Farber Cancer Institute|Takeda | Collagenous Gastritis | 2024-12-03 | PHASE2 |
| NCT03629379 | Universitaire Ziekenhuizen KU Leuven | Inflammatory Bowel Diseases|Psoriasis | 2019-01-22 | PHASE4 |
| NCT04469062 | Eli Lilly and Company | Ulcerative Colitis | 2021-04-20 | PHASE3 |
| NCT03679546 | Rennes University Hospital | Ulcerative Colitis | 2019-01-04 | PHASE4 |
| NCT03309865 | Mayo Clinic | Ulcerative Colitis|Dietary Modification | 2017-12-25 | EARLY_PHASE1 |
| NCT06045754 | Takeda | Crohn´s Disease | 2024-04-18 | PHASE4 |
| NCT03558152 | Genentech, Inc. | Ulcerative Colitis | 2018-10-26 | PHASE2 |
| NCT03237260 | University of Pennsylvania|Takeda|Corporal Michael J. Crescenz VA Medical Center | Ulcerative Colitis | 2017-07-01 | PHASE4 |
| NCT04362735 | Pontifícia Universidade Católica do Paraná|Takeda | Crohn Disease | 2020-08-01 | |
| NCT03219359 | Aaron Etra | Crohn Disease | 2018-02-22 | PHASE2 |
| NCT00655135 | Millennium Pharmaceuticals, Inc. | Crohn´s Disease | 2000-02 | PHASE2 |